Extraprostatic seed placement and its effect on seed loss

Cancer Journal

Volumn 11, Issue 2, 2005, Pages 147-151

  Nedea, Elena ^a   Wallner, Kent ^b,c,d   Reed, Daniel ^b,c   Ford, Eric ^c   Sutlief, Stephen ^b,c   Mueller, Amy ^b   Maki, Jeffrey ^b   Merrick, Gregory ^e  

^a MCGILL UNIVERSITY   (Canada)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d CENTER FOR HEALTH STUDIES   (United States)

^e WHEELING HOSPITAL   (United States)

Author keywords

Brachytherapy; CT; MR; Prostate cancer

Indexed keywords

IODINE 125;

ARTICLE; BRACHYTHERAPY; CANCER STAGING; CANCER TRANSPLANTATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FOLLOW UP; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CARCINOMA; TREATMENT PLANNING; FOREIGN BODY; METHODOLOGY; PROSTATE TUMOR; RADIATION DOSE;

BRACHYTHERAPY; FOREIGN-BODY MIGRATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33749583167     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200503000-00010     Document Type: Article

References (12)

1. Butzbach D, Waterman FM, Dicker AP. Can extraprostatic extension be treated by prostate brachytherapy? An analysis based on postimplant dosimetry. Int J Radiat Oncol Biol Phys 2001;51:1196-1199.
2. Davis BJ, Pisansky TM, Wilson TM et al. The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapy. Cancer 1999;85:2630-2637.
3. Teh B, Bastasch M, Mai W et al. Predictors of extracapsular extension and its radial distance in prostate cancer: Implications for prostate IMRT, brachytherapy, and surgery. Cancer J 2003;9:454-460.
4. Choi S, Wallner KE, Merrick G et al. Treatment margins predict biochemical outcomes after prostate brachytherapy. Cancer J 2004;10:175-180.
5. Davis BJ, Haddock MG, Wilson TM et al. Treatment of extraprostatic cancer in clinically organ-confined prostate cancer by permanent interstitial brachytherapy: is extraprostatic seed placement necessary? Tech Urol 2000;6:70-77.
6. Dattoli MJ, Wallner KE, Sorace R et al. Planned extracapsular seed placement using palladium-103 for prostate brachytherapy. J Brachyther Int 2000;16:35-43.
7. Sommerkamp H, Rupprecht M, Wannenmacher M. Seed loss in interstitial radiotherapy of prostatic carcinoma with I-125. Int J Radiat Oncol Biol Phys 1988;14:389-392.
8. Tapen EM, Blasko JC, Grimm PD et al. Reduction of radioactive seed embolization to the lung following prostate brachytherapy. Int J Radiat Oncol Biol Phys 1998;42:1063-1067.
9. Merrick GS, Butler WM, Dorsey AT et al. Seed fixity in the prostate/periprostatic region following brachytherapy. Int J Radiat Oncol Biol Phys 2000;46:215-220.
10. Merrick GS, Butler WM. Modified uniform seed loading for prostate brachytherapy: rationale, design, and evaluation. Tech Urol 2000;6:78-84.
11. Badiozamani KR, Wallner KE, Cavanagh W et al. Comparability of CT-based and TRUS-based prostate volumes. Int J Radiat Oncol Biol Phys 1999;43:375-378.
12. Willins J, Wallner KE. Time-dependent changes in CT-based dosimetry of I-125 prostate brachytherapy. Radiat Oncol Invest 1998;6:157-160.